Patient Safety Questions Linger after FDA Issues Interchangeability Guidance
New guidance from the Food and Drug Administration directs companies on how to demonstrate a biosimilar’s interchangeability with its reference product.
Who Pays the Price for Health Plans’ Soaring Profits?
UnitedHealth Group announced higher than expected earnings this week, celebrating an 18 percent year-over-year increase to $185 billion in 2106 revenue. But not everyone’s cheering.
FDA Settles on Random Suffix Approach for Naming Biologics & Biosimilars
The names of biologic and biosimilar medicines will include randomly generated four-letter suffixes, the Food and Drug Administration announced Thursday.
Advocates & Physicians Speak Out on Potential Vaccine Panel
News on Tuesday that President-elect Donald Trump may form a federal panel on vaccine safety prompted outcry from physicians and advocates.
For Affordable Care Act Patients, Cancer Treatment Access May Fall Short
About 83 percent of Americans say they could depend upon their health insurer if diagnosed with a serious illness like cancer, according to Aimed Alliance polling.
New York Governor Signs Step Therapy Bill into Law
New York Governor Andrew Cuomo has signed into law a bill that protects patients from step therapy, marking a victory for advocates in the state.
What Reduced Opioid Prescribing Means for Patients and Policy
New polling data from The Boston Globe reveals that U.S. physicians are prescribing fewer opioids. But how does the trend impact patients – and the nation’s opioid addiction epidemic?
2016 in Review: Top Trends for Patient Access
Hepatitis C patients keep waiting…and waiting…and waiting.
Hepatitis C and Opioid Abuse Epidemics Combine to Pose New Crisis
Two American public health epidemics are colliding – creating new headaches for policymakers and more heartache for communities across the country.
New Biosimilar Switching Paper Prioritizes Physician-Patient Relationship and Robust Pharmacovigilance
A new position paper from the European Crohn’s and Colitis Organisation has garnered attention from physicians and patient advocates across Europe.
